Effectiveness and Safety of Probiotics in Protecting Liver Function
ConditionAlcohol Abuse
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-65
SponsorWecare Probiotics Co., Ltd.
About this trial
To evaluate the effectiveness and safety of using probiotics to protect the liver function of long-term alcohol consumers
Eligibility criteria
Qualifiers
A history of long-term heavy alcohol consumption, equivalent to ethanol intake ≥40g/day for over 1 year. The conversion formula is: ethanol (g) = volume of ethanol-containing beverage (mL) × ethanol content (%) × 0.8 (specific gravity of ethanol);
Body Mass Index (BMI) between 18kg/m² and 25kg/m²;
Voluntarily signed a written informed consent form, agreeing to participate in this study;
Agreed to comply with the study protocol and restrictions;
Disqualifiers
Patients with various types of viral hepatitis, autoimmune liver disease, drug-induced liver damage, vascular liver disease, genetic metabolic liver disease, or primary liver cancer;
Individuals who have recently consumed substances with similar functions to the tested product, potentially affecting the study results;
Patients with severe allergies or immune deficiencies;
Pregnant, breastfeeding, or women with plans for pregnancy;
Trial design
Treatments tested in this trial
- Probiotic group
- Placebo group
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov